Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Fenimore Christopher R.. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Fenimore Christopher R. reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:REGN / Regeneron Pharmaceuticals, Inc. EVP Finance CFO 18,300
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Fenimore Christopher R.. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Fenimore Christopher R. conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2025-12-09 2025-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -992 18,300 -5.14 712.94 -707,236 13,046,802
2025-12-09 2025-12-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 3,027 19,292 18.61
2024-12-18 2024-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -491 16,265 -2.93 730.81 -358,828 11,886,625
2024-12-10 2024-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,140 16,756 -6.37 787.00 -897,180 13,186,972
2024-12-10 2024-12-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,591 17,896 16.93
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 25 -88.89 1,206.67 -241,334 30,167
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -235 225 -51.09 1,205.67 -283,332 271,276
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 25 -88.89 1,206.70 -241,340 30,168
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -236 225 -51.19 1,205.67 -284,538 271,276
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -450 0 -100.00 1,206.15 -542,768
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -928 450 -67.34 1,205.49 -1,118,695 542,470
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -2,237 1,378 -61.88 1,204.71 -2,694,936 1,660,090
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -200 0 -100.00 1,206.30 -241,260
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -766 200 -79.30 1,205.44 -923,367 241,088
2024-08-29 2024-08-28 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -228 966 -19.10 1,204.79 -274,692 1,163,827
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -600 14,372 -4.01 955.00 -573,000 13,725,260
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,100 14,972 -6.84 954.57 -1,050,027 14,291,822
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,342 16,072 -7.71 953.47 -1,279,557 15,324,170
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -1,046 17,414 -5.67 952.62 -996,441 16,588,925
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -487 18,460 -2.57 951.39 -463,327 17,562,659
2024-02-12 2024-02-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale -344 18,947 -1.78 950.49 -326,969 18,008,934
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,583 19,291 -15.66 948.50 -3,398,476 18,297,514
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 22,874 27.97 399.66 1,998,300 9,141,823
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,986 17,874 -18.23 948.50 -3,780,721 16,953,489
2024-01-25 2024-01-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 21,860 29.66 555.67 2,778,350 12,146,946
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,469 16,860 -17.06 912.30 -3,164,769 15,381,378
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 20,329 32.62 399.66 1,998,300 8,124,688
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -4,043 15,329 -20.87 912.30 -3,688,429 13,984,647
2024-01-04 2024-01-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 19,372 34.79 555.67 2,778,350 10,764,439
2023-12-29 2023-12-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,448 14,372 -14.55 856.71 -2,097,226 12,312,636
2023-12-26 2023-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -250 16,820 -1.46 846.27 -211,568 14,234,261
2023-12-26 2023-12-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,224 17,070 -6.69 844.09 -1,033,166 14,408,616
2023-12-26 2023-12-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -456 18,294 -2.43 843.79 -384,768 15,436,294
2023-12-14 2023-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,552 18,750 -11.98 856.71 -2,186,324 16,063,312
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -260 21,302 -1.21 844.09 -219,463 17,980,805
2023-12-12 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,276 21,562 -5.59 844.09 -1,077,059 18,200,269
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,370 22,838 11.58
2023-12-12 2023-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -474 20,468 -2.26 843.79 -399,956 17,270,694
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -5,198 20,942 -19.89 842.66 -4,380,147 17,646,986
2023-08-25 2023-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 7,000 26,140 36.57 399.66 2,797,620 10,447,112
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -2,192 18,409 -10.64 806.47 -1,767,782 14,846,306
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,286 20,295 -13.93 774.29 -2,544,317 15,714,216
2023-02-07 2023-02-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 23,581 26.91 270.43 1,352,150 6,377,010
2022-12-20 2022-12-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1,926 18,581 11.56
2022-12-13 2022-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -247 16,655 -1.46 753.28 -186,060 12,545,878
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 435 460 1,740.00
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 436 461 1,744.00
2022-12-13 2022-10-26 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -871 0 -100.00
2022-10-07 2022-10-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,844 16,425 -10.09 749.00 -1,381,156 12,302,325
2022-10-05 2022-10-03 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3,346 18,269 -15.48 724.00 -2,422,504 13,226,756
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -2,450 10,000 -19.68
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -5,000 5,000 -50.00
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -3,451 26,615 -11.48 736.21 -2,540,661 19,594,229
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 5,000 30,066 19.95 270.43 1,352,150 8,130,748
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -2,155 25,066 -7.92 736.21 -1,586,533 18,453,840
2022-04-11 2022-04-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,450 27,221 9.89 555.67 1,361,392 15,125,893
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -2,000 12,450 -13.84
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise -10,000 10,000 -50.00
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -6,857 24,771 -21.68 700.99 -4,806,688 17,364,223
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 10,000 31,628 46.24 270.43 2,704,300 8,553,160
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -1,797 21,628 -7.67 700.99 -1,259,679 15,161,012
2022-04-01 2022-03-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,000 23,425 9.33 555.67 1,111,340 13,016,570
2021-12-14 2021-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes -270 21,122 -1.26 664.34 -179,372 14,032,189
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 7,941 7,941
2021-12-10 2021-12-08 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1,859 21,392 9.52
2021-08-25 2021-08-20 4/A REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -8,719 19,020 -31.43 664.85 -5,796,827 12,645,447
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -14 27,739 -0.05 665.21 -9,313 18,452,260
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -70 27,753 -0.25 663.05 -46,414 18,401,627
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1 27,823 0.00 662.78 -663 18,440,528
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -88 27,824 -0.32 661.89 -58,246 18,416,427
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -23 27,912 -0.08 660.33 -15,188 18,431,131
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -9 27,935 -0.03 659.33 -5,934 18,418,384
2021-08-24 2021-08-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,576 27,944 -14.07 655.00 -2,997,280 18,303,320
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -13,500 0 -100.00
2021-08-24 2021-08-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 13,500 32,520 70.98 179.13 2,418,255 5,825,308
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 10,000 10,000
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1,750 21,102 9.04
2020-12-11 2020-12-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 969 19,352 5.27
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 25 25
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift 25 25
2020-12-11 2020-09-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
G - Gift -50 0 -100.00
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -11 17,501 -0.06 658.00 -7,238 11,515,658
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -82 17,512 -0.47 647.79 -53,119 11,344,098
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -155 17,594 -0.87 646.82 -100,257 11,380,151
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -72 17,749 -0.40 645.33 -46,464 11,453,962
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -303 17,821 -1.67 644.57 -195,305 11,486,882
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -691 18,124 -3.67 643.49 -444,652 11,662,613
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -676 18,815 -3.47 642.39 -434,256 12,086,568
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -855 19,491 -4.20 641.58 -548,551 12,505,036
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -113 20,346 -0.55 640.61 -72,389 13,033,851
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -75 20,459 -0.37 639.64 -47,973 13,086,395
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -306 20,534 -1.47 638.51 -195,384 13,111,164
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -154 20,840 -0.73 637.88 -98,234 13,293,419
2020-07-22 2020-07-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -216 20,994 -1.02 636.56 -137,497 13,363,941
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -10,000 13,500 -42.55
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -2,224 0 -100.00
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,224 21,210 11.71 52.03 115,715 1,103,556
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -6,291 18,986 -24.89 655.57 -4,124,191 12,446,652
2020-07-22 2020-07-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10,000 25,277 65.46 179.13 1,791,300 4,527,869
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -294 15,277 -1.89 596.36 -175,330 9,110,592
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -403 15,571 -2.52 595.50 -239,986 9,272,530
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -747 15,974 -4.47 594.35 -443,979 9,494,147
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -109 16,721 -0.65 593.25 -64,664 9,919,733
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -214 16,830 -1.26 592.20 -126,731 9,966,726
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -233 17,044 -1.35 591.61 -137,845 10,083,401
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -153 17,277 -0.88 590.70 -90,377 10,205,524
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -147 17,430 -0.84 588.80 -86,554 10,262,784
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -373 17,577 -2.08 587.55 -219,156 10,327,366
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -413 17,950 -2.25 586.54 -242,241 10,528,393
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -130 18,363 -0.70 585.76 -76,149 10,756,311
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -99 18,493 -0.53 584.62 -57,877 10,811,378
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -111 18,592 -0.59 583.06 -64,720 10,840,252
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -18 18,703 -0.10 582.69 -10,488 10,898,051
2020-06-17 2020-06-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -112 18,721 -0.59 581.40 -65,117 10,884,389
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -7,226 0 -100.00
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -2,180 0 -100.00
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2,180 18,833 13.09 30.63 66,773 576,855
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -3,670 16,653 -18.06 587.90 -2,157,593 9,790,299
2020-06-17 2020-06-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 7,226 20,323 55.17 52.03 375,969 1,057,406
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise X -1,200 2,180 -35.50
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -68 13,097 -0.52 497.99 -33,863 6,522,175
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -37 13,165 -0.28 494.16 -18,284 6,505,616
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -174 13,202 -1.30 493.24 -85,824 6,511,754
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -134 13,376 -0.99 492.45 -65,988 6,587,011
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -70 13,510 -0.52 491.65 -34,416 6,642,192
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -201 13,580 -1.46 489.48 -98,385 6,647,138
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -137 13,781 -0.98 488.76 -66,960 6,735,602
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -3 13,918 -0.02 484.14 -1,452 6,738,261
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -124 13,921 -0.88 483.58 -59,964 6,731,917
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -62 14,045 -0.44 482.09 -29,890 6,770,954
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -58 14,107 -0.41 480.28 -27,856 6,775,310
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -69 14,165 -0.48 479.00 -33,051 6,785,035
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -63 14,234 -0.44 478.77 -30,163 6,814,812
2020-04-03 2020-04-01 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1,200 14,297 9.16 30.63 36,756 437,917
2020-01-27 2020-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -500 3,380 -12.89
2020-01-27 2020-01-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 500 13,097 3.97 30.63 15,315 401,161
2019-12-23 2019-12-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Incentive Stock Option (right to buy)
M - Exercise -400 3,880 -9.35
2019-12-23 2019-12-20 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise 400 12,597 3.28 30.63 12,252 385,846
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -51 12,197 -0.42 378.27 -19,292 4,613,759
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -346 12,248 -2.75 377.38 -130,573 4,622,150
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -470 12,594 -3.60 376.27 -176,847 4,738,744
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -624 13,064 -4.56 375.58 -234,362 4,906,577
2019-12-13 2019-12-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
S - Sale X -191 13,688 -1.38 374.82 -71,591 5,130,536
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -3,100 7,226 -30.02
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
F - Taxes X -1,418 13,879 -9.27 377.16 -534,813 5,234,604
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3,100 15,297 25.42 52.03 161,293 795,903
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 6,120 6,120
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 2,500 12,197 25.78
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock
A - Award 1,020 9,697 11.76
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -350 0 -100.00
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 350 1,897 22.62
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -350 7,096 -4.70
2019-04-18 2019-04-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 350 7,446 4.93 21.25 7,438 158,228
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -150 350 -30.00
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 150 1,547 10.74
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -150 7,096 -2.07
2019-01-18 2019-01-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 150 7,246 2.11 21.25 3,188 153,978
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -675 500 -57.45
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 7,096 -2.74 362.45 -72,490 2,571,945
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 7,296 -1.35 361.65 -36,165 2,638,598
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -500 7,396 -6.33 360.40 -180,200 2,665,518
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 7,896 -2.47 359.38 -71,876 2,837,664
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 8,096 -2.41 358.27 -71,654 2,900,554
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -200 8,296 -2.35 357.50 -71,500 2,965,820
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -348 8,496 -3.93 356.27 -123,982 3,026,870
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
S - Sale X -100 8,844 -1.12 355.14 -35,514 3,140,858
2018-12-20 2018-12-20 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 675 8,944 8.16 21.25 14,344 190,060
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
M - Exercise X -3,450 10,326 -25.04
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
F - Taxes X -1,602 8,269 -16.23 364.42 -583,801 3,013,389
2018-12-20 2018-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise X 3,450 9,871 53.73 52.03 179,504 513,588
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 11,400 11,400
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
A - Award 5,000 6,421 351.86
2018-12-14 2018-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 2,950 2,950
2018-12-14 2018-10-25 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -2,950 1,397 -67.86
2018-12-14 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift 50 4,347 1.16
2018-12-14 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
G - Gift -50 1,421 -3.40
2018-08-31 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -50 1,175 -4.08
2018-08-31 2018-08-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 50 200 33.33 21.25 1,062 4,250
2018-01-17 2018-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy)
M - Exercise -150 1,225 -10.91
2018-01-17 2018-01-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock
M - Exercise 150 150 21.25 3,188 3,188
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy)
A - Award 12,300 12,300
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
9,648
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
11,015
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
12,617
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
9,648
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
11,015
2017-03-02 3 REGN REGENERON PHARMACEUTICALS INC
Common Stock
12,617
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)